Gene Therapy for severe Hemophilia has new Phase I/II Results
uniQure has new data from the Phase I/II trial of its gene therapy for Hemophilia…
uniQure has new data from the Phase I/II trial of its gene therapy for Hemophilia…
Sobi has received market approval by the European Comission for Alprolix, a long-duration protein therapy…
The Hemophilia Aid Program has just touched down the first batch of treatments in its…
Berlin is growing as a massive Biotech hub, in part thanks to prestigious University of…
Now, as we've recently discussed here at Labiotech, there doesn't appear to be many Welsh…
In the 19th century, Queen Victoria passed the Hemophilia B to diverse royal houses of…
Apitope’s pre-clinical candidate ATX-F8-117 has been granted Orphan Drug Status by the US FDA for…
Bayer HealthCare, a subgroup of Bayer AG, is one of the world's leading, innovative companies…